Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and Eisai Inc. announced that new data analyses from the lorcaserin Phase 3 clinical trial program will be presented in poster sessions at Obesity 2011, the 29th Annual Scientific Meeting of The Obesity Society in Orlando, Florida. The posters highlighted below will be displayed in the Cypress Ballroom of the Orlando World Center Marriott on October 3, 2011, from 9:30 a.m. to 1:45 p.m. Eastern Time (ET) and from 3:15 p.m. to 6:30 p.m. ET. Authors will be available at the posters on October 3, 2011, from 12:30 p.m. to 1:30 p.m. ET.
Read the full article and disclaimer at: http://pennyomega.com/?p=17484
(ARNA, CLNO, OSN, SNSS) Featured Stocks by PennyOmega.com
September 30th, 2011 at 01:00 pm